{"id":3962,"date":"2025-03-17T08:00:33","date_gmt":"2025-03-17T11:00:33","guid":{"rendered":"https:\/\/www.atlanticpath.ca\/?p=3962"},"modified":"2025-03-13T13:06:40","modified_gmt":"2025-03-13T16:06:40","slug":"canpath-data-sheds-light-on-air-pollutions-hidden-role-in-rheumatic-disease","status":"publish","type":"post","link":"https:\/\/www.atlanticpath.ca\/index.php\/2025\/03\/17\/canpath-data-sheds-light-on-air-pollutions-hidden-role-in-rheumatic-disease\/","title":{"rendered":"CanPath data sheds light on air pollution\u2019s hidden role in rheumatic disease"},"content":{"rendered":"

<\/p>\n

Air pollution isn\u2019t just a lung issue. It has far-reaching effects on immune function and autoimmune diseases. CanPath\u2019s vast dataset offers researchers a unique opportunity to explore these connections and advance air pollution and autoimmune disease research.<\/em><\/p>\n

Air pollution is often associated with respiratory conditions, but emerging research reveals its impact extends beyond the lungs, influencing immune system function and contributing to autoimmune and rheumatic diseases. Understanding these connections is critical for disease prevention, treatment, and public health strategies.<\/p>\n

\"Dr.
<\/figcaption><\/figure>\n

Dr. Sasha Bernatsky<\/a>, a rheumatologist and epidemiologist, has been at the forefront of this research. Her work highlights how air pollution, especially fine particulate matter (PM2.5<\/sub>), may act as an environmental trigger for immune dysfunction.\u00a0CanPath<\/a>, Canada\u2019s largest population health study, provides researchers with the data needed to examine these links in depth.<\/p>\n

How air pollution affects the immune system and autoimmune disease<\/h2>\n

Air pollutants include PM2.5<\/sub>, nitrogen dioxide (NO2<\/sub>), ozone, and other entities. PM2.5<\/sub>\u00a0can enter the bloodstream, triggering systemic inflammation and immune dysregulation. While air pollution\u2019s effects on respiratory conditions like asthma and lung cancer are well documented, its role in autoimmune diseases is a newer area of investigation.<\/p>\n

\u201cOne of the really cool things about these kinds of analyses was that it provided one of the first indications that air pollution may affect the immune system,\u201d said Dr. Bernatsky. \u201cPrior to these kinds of analyses, we had good data on what happens when you are exposed to PM2.5<\/sub>\u00a0in terms of asthma risk or lung cancer. That makes sense because you breathe in the air, and there\u2019s a local effect. But this was one of the first analyses looking at a totally different kind of disease. It convinced people at Health Canada\u2019s air health effects assessment division that, indeed, you can have health effects far beyond just the lung.\u201d<\/p>\n

This growing body of research underscores the need for large-scale, longitudinal data to better understand the full spectrum of air pollution\u2019s impact on immune-mediated conditions like rheumatoid arthritis and systemic lupus.<\/p>\n

CanPath\u2019s role in advancing rheumatic disease research<\/h2>\n

Arthritis data resources in CanPath: Biosamples, genotyping, and self-reported diagnoses for osteoarthritis, rheumatoid arthritis, and other forms<\/p>\n

\"\"
<\/figcaption><\/figure>\n
<\/div>\n

CanPath\u2019s large-scale, longitudinal dataset is an invaluable resource for researchers undertaking air pollution and autoimmune disease research. By linking environmental exposure data to genetic, lifestyle, and health information, CanPath enables scientists to explore how air pollution contributes to immune-mediated diseases over time.<\/p>\n

\u201cCanPath serum samples and data were extremely helpful,\u201d Dr. Bernatsky emphasized. \u201cIn fact, I just don\u2019t see any way we could have done what we did without CanPath.\u201d<\/p>\n

\"Dr.
<\/figcaption><\/figure>\n
\u00a0Dr. Trevor Dummer<\/a>, an expert in environmental health, reflected on the study\u2019s evolution and its potential for continued discoveries: \u201cIt\u2019s nice to see some of those results because I can think back to many, many years ago. You know, CanPath has been going for 15 years. Now it\u2019s a considerable amount of time. I recall the early collaboration, so it\u2019s great to see the fruits of all of those labours.\u201d<\/div>\n

This extensive dataset allows researchers to track patterns over time, assessing how long-term exposure to air pollution affects disease development and progression.<\/p>\n

Implications for future research and public health<\/h2>\n

The insights gained from CanPath\u2019s data have the potential to:<\/p>\n